Loading…

Long-term Outcome of Autologous Lipoinjection Medialization Laryngoplasty versus Type I Thyroplasty

Glottic insufficiency is incomplete or soft closure of the true vocal folds during phonation, and is a common cause of dysphonia. Treatment includes voice therapy, type I thyroplasty, vocal fold injection augmentation (with materials such as autologous fat), arytenoid cartilage repositioning, or a c...

Full description

Saved in:
Bibliographic Details
Published in:Journal of voice 2023-11
Main Authors: Balouch, Bailey, Maxwell, Philip J., Vontela, Swetha, Sataloff, Robert T.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c203t-6b67d1e14df8e2c495a54adebe239dae72cc4eed87abe970599527dfc810bce63
container_end_page
container_issue
container_start_page
container_title Journal of voice
container_volume
creator Balouch, Bailey
Maxwell, Philip J.
Vontela, Swetha
Sataloff, Robert T.
description Glottic insufficiency is incomplete or soft closure of the true vocal folds during phonation, and is a common cause of dysphonia. Treatment includes voice therapy, type I thyroplasty, vocal fold injection augmentation (with materials such as autologous fat), arytenoid cartilage repositioning, or a combination of treatment modalities. The present study aimed to compare long-term outcomes of lipoinjection medialization with type I thyroplasty for patients with glottic insufficiency. Adult voice center patients who had undergone surgical vocal fold medialization with autologous lipoinjection or with type I thyroplasty for glottic insufficiency were included in this retrospective study. The primary outcome measures were need for further medialization surgery, and improvement in the glottic gap. There were 172 subjects included in this study: 100 subjects underwent type I thyroplasty and 72 subjects underwent autologous lipoinjection medialization. Neither age nor gender differed significantly between thyroplasty and lipoinjection groups. The rate of further medialization surgery did not differ significantly between thyroplasty and lipoinjection groups, but further medialization surgery was performed longer after the initial operation in the thyroplasty group Baseline glottic gap did not differ significantly between thyroplasty and lipoinjection groups. When improvement from baseline was compared between thyroplasty and lipoinjection subjects, the improvement from baseline was similar for both groups at six months and at 12 months. Voice handicap index scores improved significantly after thyroplasty or after lipoinjection, and the improvement from baseline was similar in both cohorts. Both autologous lipoinjection medialization and type I thyroplasty provide effective medialization for patients with glottic insufficiency. Both techniques yield similar reoperation rates, and the benefit of surgery appears to last for at least one year for most patients.
doi_str_mv 10.1016/j.jvoice.2023.10.012
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2888035903</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0892199723003211</els_id><sourcerecordid>2888035903</sourcerecordid><originalsourceid>FETCH-LOGICAL-c203t-6b67d1e14df8e2c495a54adebe239dae72cc4eed87abe970599527dfc810bce63</originalsourceid><addsrcrecordid>eNp9kEtPwzAQhC0EEqXwDzjkyCXBdl72BamqeFQK6qWcLcfZFEdJHOykUvj1uIQzp9XO7ow0H0L3BEcEk-yxiZqT0QoiimnspQgTeoFWhOVxmKSMXaIVZpyGhPP8Gt0412CMqb-ukCpMfwxHsF2wn0ZlOghMHWym0bTmaCYXFHowum9Ajdr0wTtUWrb6W_5uhbRzfzRDK904ByewzhsO8wDBLjh8zvbvcouuatk6uPuba_Tx8nzYvoXF_nW33RShojgew6zM8ooASaqaAVUJT2WayApKoDGvJORUqQSgYrksgec45TyleVUrRnCpIIvX6GHJHaz5msCNotNOQdvKHnwVQRljOE45jv1rsrwqa5yzUIvB6s7XEQSLM1PRiIWpODM9q56ptz0tNvA1ThqscEpDrzwV6wmJyuj_A34A0RmE8w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2888035903</pqid></control><display><type>article</type><title>Long-term Outcome of Autologous Lipoinjection Medialization Laryngoplasty versus Type I Thyroplasty</title><source>ScienceDirect Journals</source><creator>Balouch, Bailey ; Maxwell, Philip J. ; Vontela, Swetha ; Sataloff, Robert T.</creator><creatorcontrib>Balouch, Bailey ; Maxwell, Philip J. ; Vontela, Swetha ; Sataloff, Robert T.</creatorcontrib><description>Glottic insufficiency is incomplete or soft closure of the true vocal folds during phonation, and is a common cause of dysphonia. Treatment includes voice therapy, type I thyroplasty, vocal fold injection augmentation (with materials such as autologous fat), arytenoid cartilage repositioning, or a combination of treatment modalities. The present study aimed to compare long-term outcomes of lipoinjection medialization with type I thyroplasty for patients with glottic insufficiency. Adult voice center patients who had undergone surgical vocal fold medialization with autologous lipoinjection or with type I thyroplasty for glottic insufficiency were included in this retrospective study. The primary outcome measures were need for further medialization surgery, and improvement in the glottic gap. There were 172 subjects included in this study: 100 subjects underwent type I thyroplasty and 72 subjects underwent autologous lipoinjection medialization. Neither age nor gender differed significantly between thyroplasty and lipoinjection groups. The rate of further medialization surgery did not differ significantly between thyroplasty and lipoinjection groups, but further medialization surgery was performed longer after the initial operation in the thyroplasty group Baseline glottic gap did not differ significantly between thyroplasty and lipoinjection groups. When improvement from baseline was compared between thyroplasty and lipoinjection subjects, the improvement from baseline was similar for both groups at six months and at 12 months. Voice handicap index scores improved significantly after thyroplasty or after lipoinjection, and the improvement from baseline was similar in both cohorts. Both autologous lipoinjection medialization and type I thyroplasty provide effective medialization for patients with glottic insufficiency. Both techniques yield similar reoperation rates, and the benefit of surgery appears to last for at least one year for most patients.</description><identifier>ISSN: 0892-1997</identifier><identifier>EISSN: 1873-4588</identifier><identifier>DOI: 10.1016/j.jvoice.2023.10.012</identifier><language>eng</language><publisher>Elsevier Inc</publisher><subject>Autologous Lipoinjection Medialization Laryngoplasty ; Fat Injection ; Glottic Closure ; Glottic Insufficiency ; Long Term Outcomes ; Type I Thyroplasty</subject><ispartof>Journal of voice, 2023-11</ispartof><rights>2023</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c203t-6b67d1e14df8e2c495a54adebe239dae72cc4eed87abe970599527dfc810bce63</cites><orcidid>0000-0002-7016-1374</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Balouch, Bailey</creatorcontrib><creatorcontrib>Maxwell, Philip J.</creatorcontrib><creatorcontrib>Vontela, Swetha</creatorcontrib><creatorcontrib>Sataloff, Robert T.</creatorcontrib><title>Long-term Outcome of Autologous Lipoinjection Medialization Laryngoplasty versus Type I Thyroplasty</title><title>Journal of voice</title><description>Glottic insufficiency is incomplete or soft closure of the true vocal folds during phonation, and is a common cause of dysphonia. Treatment includes voice therapy, type I thyroplasty, vocal fold injection augmentation (with materials such as autologous fat), arytenoid cartilage repositioning, or a combination of treatment modalities. The present study aimed to compare long-term outcomes of lipoinjection medialization with type I thyroplasty for patients with glottic insufficiency. Adult voice center patients who had undergone surgical vocal fold medialization with autologous lipoinjection or with type I thyroplasty for glottic insufficiency were included in this retrospective study. The primary outcome measures were need for further medialization surgery, and improvement in the glottic gap. There were 172 subjects included in this study: 100 subjects underwent type I thyroplasty and 72 subjects underwent autologous lipoinjection medialization. Neither age nor gender differed significantly between thyroplasty and lipoinjection groups. The rate of further medialization surgery did not differ significantly between thyroplasty and lipoinjection groups, but further medialization surgery was performed longer after the initial operation in the thyroplasty group Baseline glottic gap did not differ significantly between thyroplasty and lipoinjection groups. When improvement from baseline was compared between thyroplasty and lipoinjection subjects, the improvement from baseline was similar for both groups at six months and at 12 months. Voice handicap index scores improved significantly after thyroplasty or after lipoinjection, and the improvement from baseline was similar in both cohorts. Both autologous lipoinjection medialization and type I thyroplasty provide effective medialization for patients with glottic insufficiency. Both techniques yield similar reoperation rates, and the benefit of surgery appears to last for at least one year for most patients.</description><subject>Autologous Lipoinjection Medialization Laryngoplasty</subject><subject>Fat Injection</subject><subject>Glottic Closure</subject><subject>Glottic Insufficiency</subject><subject>Long Term Outcomes</subject><subject>Type I Thyroplasty</subject><issn>0892-1997</issn><issn>1873-4588</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kEtPwzAQhC0EEqXwDzjkyCXBdl72BamqeFQK6qWcLcfZFEdJHOykUvj1uIQzp9XO7ow0H0L3BEcEk-yxiZqT0QoiimnspQgTeoFWhOVxmKSMXaIVZpyGhPP8Gt0412CMqb-ukCpMfwxHsF2wn0ZlOghMHWym0bTmaCYXFHowum9Ajdr0wTtUWrb6W_5uhbRzfzRDK904ByewzhsO8wDBLjh8zvbvcouuatk6uPuba_Tx8nzYvoXF_nW33RShojgew6zM8ooASaqaAVUJT2WayApKoDGvJORUqQSgYrksgec45TyleVUrRnCpIIvX6GHJHaz5msCNotNOQdvKHnwVQRljOE45jv1rsrwqa5yzUIvB6s7XEQSLM1PRiIWpODM9q56ptz0tNvA1ThqscEpDrzwV6wmJyuj_A34A0RmE8w</recordid><startdate>20231106</startdate><enddate>20231106</enddate><creator>Balouch, Bailey</creator><creator>Maxwell, Philip J.</creator><creator>Vontela, Swetha</creator><creator>Sataloff, Robert T.</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7016-1374</orcidid></search><sort><creationdate>20231106</creationdate><title>Long-term Outcome of Autologous Lipoinjection Medialization Laryngoplasty versus Type I Thyroplasty</title><author>Balouch, Bailey ; Maxwell, Philip J. ; Vontela, Swetha ; Sataloff, Robert T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c203t-6b67d1e14df8e2c495a54adebe239dae72cc4eed87abe970599527dfc810bce63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Autologous Lipoinjection Medialization Laryngoplasty</topic><topic>Fat Injection</topic><topic>Glottic Closure</topic><topic>Glottic Insufficiency</topic><topic>Long Term Outcomes</topic><topic>Type I Thyroplasty</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Balouch, Bailey</creatorcontrib><creatorcontrib>Maxwell, Philip J.</creatorcontrib><creatorcontrib>Vontela, Swetha</creatorcontrib><creatorcontrib>Sataloff, Robert T.</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of voice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Balouch, Bailey</au><au>Maxwell, Philip J.</au><au>Vontela, Swetha</au><au>Sataloff, Robert T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-term Outcome of Autologous Lipoinjection Medialization Laryngoplasty versus Type I Thyroplasty</atitle><jtitle>Journal of voice</jtitle><date>2023-11-06</date><risdate>2023</risdate><issn>0892-1997</issn><eissn>1873-4588</eissn><abstract>Glottic insufficiency is incomplete or soft closure of the true vocal folds during phonation, and is a common cause of dysphonia. Treatment includes voice therapy, type I thyroplasty, vocal fold injection augmentation (with materials such as autologous fat), arytenoid cartilage repositioning, or a combination of treatment modalities. The present study aimed to compare long-term outcomes of lipoinjection medialization with type I thyroplasty for patients with glottic insufficiency. Adult voice center patients who had undergone surgical vocal fold medialization with autologous lipoinjection or with type I thyroplasty for glottic insufficiency were included in this retrospective study. The primary outcome measures were need for further medialization surgery, and improvement in the glottic gap. There were 172 subjects included in this study: 100 subjects underwent type I thyroplasty and 72 subjects underwent autologous lipoinjection medialization. Neither age nor gender differed significantly between thyroplasty and lipoinjection groups. The rate of further medialization surgery did not differ significantly between thyroplasty and lipoinjection groups, but further medialization surgery was performed longer after the initial operation in the thyroplasty group Baseline glottic gap did not differ significantly between thyroplasty and lipoinjection groups. When improvement from baseline was compared between thyroplasty and lipoinjection subjects, the improvement from baseline was similar for both groups at six months and at 12 months. Voice handicap index scores improved significantly after thyroplasty or after lipoinjection, and the improvement from baseline was similar in both cohorts. Both autologous lipoinjection medialization and type I thyroplasty provide effective medialization for patients with glottic insufficiency. Both techniques yield similar reoperation rates, and the benefit of surgery appears to last for at least one year for most patients.</abstract><pub>Elsevier Inc</pub><doi>10.1016/j.jvoice.2023.10.012</doi><orcidid>https://orcid.org/0000-0002-7016-1374</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0892-1997
ispartof Journal of voice, 2023-11
issn 0892-1997
1873-4588
language eng
recordid cdi_proquest_miscellaneous_2888035903
source ScienceDirect Journals
subjects Autologous Lipoinjection Medialization Laryngoplasty
Fat Injection
Glottic Closure
Glottic Insufficiency
Long Term Outcomes
Type I Thyroplasty
title Long-term Outcome of Autologous Lipoinjection Medialization Laryngoplasty versus Type I Thyroplasty
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T18%3A06%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-term%20Outcome%20of%20Autologous%20Lipoinjection%20Medialization%20Laryngoplasty%20versus%20Type%20I%20Thyroplasty&rft.jtitle=Journal%20of%20voice&rft.au=Balouch,%20Bailey&rft.date=2023-11-06&rft.issn=0892-1997&rft.eissn=1873-4588&rft_id=info:doi/10.1016/j.jvoice.2023.10.012&rft_dat=%3Cproquest_cross%3E2888035903%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c203t-6b67d1e14df8e2c495a54adebe239dae72cc4eed87abe970599527dfc810bce63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2888035903&rft_id=info:pmid/&rfr_iscdi=true